Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597 - Concepedia

Concepedia

Publication | Open Access

Randomized, Double-Blind, Placebo-Controlled, Phase III Chemoprevention Trial of Selenium Supplementation in Patients With Resected Stage I Non–Small-Cell Lung Cancer: ECOG 5597

DOI Full Paper Access

129

Citations

36

References

2013

Year

Daniel D. Karp, Sandra J. Lee, Steven M. Keller, Gail S. Wright, Seena C. Aisner, Steven A. Belinsky, David H. Johnson, Michael R. Johnston, Gary E. Goodman, Gerald H. Clamon,

Journal of Clinical Oncology

Abstract

Selenium was safe but conferred no benefit over placebo in the prevention of SPT in patients with resected NSCLC.

References

	Year	Citations

Page 1